Subscribe To
BCDA / BioCardia to Host Q2 2022 Financial Results and Corporate Update Conference Call on August 10, 2022
BCDA News
By GlobeNewsWire
November 1, 2023
BioCardia to Host Q3 2023 Corporate Update and Financial Results Conference Call on November 8, 2023
SUNNYVALE, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the tr more_horizontal
By Zacks Investment Research
October 12, 2023
BioCardia (BCDA) Up on Plans for Second Heart Failure Study
BioCardia (BCDA) completes enrollment in a pivotal phase III study on its CardiAMP cell therapy for the treatment of heart failure. It plans to begin more_horizontal
By Zacks Investment Research
September 6, 2023
BioCardia (BCDA) Dips 26% on Flunking Heart Failure Study
Based on one-year follow-up data from a pivotal phase III study, BioCardia (BCDA) reveals that its CardiAMP cell therapy is unlikely to achieve the pr more_horizontal
By Proactive Investors
September 5, 2023
BioCardia shares slide on disappointing interim data from heart therapy trial
BioCardia shares fell more than 20% in pre-market trade on Tuesday after the biopharmaceutical firm revealed that its Phase 3 trial of CardiAMP cell t more_horizontal
By Zacks Investment Research
August 9, 2023
BioCardia, Inc. (BCDA) Reports Q2 Loss, Lags Revenue Estimates
BioCardia, Inc. (BCDA) came out with a quarterly loss of $0.17 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to loss more_horizontal
By GlobeNewsWire
May 3, 2023
BioCardia to Host Q1 2023 Financial Results and Corporate Update Conference Call on May 10, 2023
SUNNYVALE, Calif., May 03, 2023 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the tre more_horizontal
By Seeking Alpha
March 29, 2023
BioCardia, Inc. (BCDA) Q4 2022 Earnings Call Transcript
BioCardia, Inc. (NASDAQ:BCDA ) Q4 2022 Earnings Conference Call March 29, 2023 4:30 PM ET Company Participants Peter Altman - President & CEO David Mc more_horizontal
By Seeking Alpha
November 12, 2022
BioCardia, Inc. (BCDA) Q3 2022 Earnings Call Transcript
BioCardia, Inc. (NASDAQ:BCDA ) Q3 2022 Earnings Conference Call November 9, 2022 4:30 PM ET Company Participants Jules Abraham - CORE IR Peter Altman more_horizontal